YAP1 and renal cell carcinoma: ZnO NPs downregulate YAP expression, repress GPX4 and SLC7A11, and increase reactive oxygen species (ROS) and iron levels, inhibiting RCC invasion, migration, and proliferation in vivo and in vitro.